S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
Log in
NASDAQ:HBIO

Harvard Bioscience Stock Forecast, Price & News

$4.27
-0.07 (-1.61 %)
(As of 01/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.25
Now: $4.27
$4.49
50-Day Range
$3.89
MA: $4.20
$4.50
52-Week Range
$1.39
Now: $4.27
$4.65
Volume143,660 shs
Average Volume142,178 shs
Market Capitalization$166.43 million
P/E RatioN/A
Dividend YieldN/A
Beta1.73
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue, organ, and animal based lab research; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. The company also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems for use with custom amplifier configurations, vivo-systems solution for in vivo recordings with microelectrode arrays, and vitro-systems for extracellular recordings from microelectrode arrays in vitro; and offers preclinical products, systems, services, and solutions with a focus on physiologic monitoring solutions. It markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. The company primarily sells its products under Harvard Apparatus, Biochrom, Hoefer, Panlab, Warner Instruments, Hugo Sachs Elektronik, Scie-Plas, BTX, Multi Channel Systems, HEKA, DSI, Ponemah, and Buxco brand names in North America, Europe, and internationally. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.
Harvard Bioscience logo

MarketRank

Overall MarketRank

1.44 out of 5 stars

Analyst Opinion: 1.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
Current SymbolNASDAQ:HBIO
CUSIP41690610
Phone508-893-8999
Employees505

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$116.18 million
Cash Flow$0.35 per share
Book Value$2.15 per share

Profitability

Net Income$-4,690,000.00

Miscellaneous

Market Cap$166.43 million
Next Earnings Date2/24/2021 (Estimated)
OptionableOptionable
$4.27
-0.07 (-1.61 %)
(As of 01/19/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for HBIO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Harvard Bioscience (NASDAQ:HBIO) Frequently Asked Questions

How has Harvard Bioscience's stock price been impacted by COVID-19 (Coronavirus)?

Harvard Bioscience's stock was trading at $2.47 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HBIO shares have increased by 72.9% and is now trading at $4.27.
View which stocks have been most impacted by COVID-19
.

Is Harvard Bioscience a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Harvard Bioscience in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Harvard Bioscience stock.
View analyst ratings for Harvard Bioscience
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Harvard Bioscience?

Wall Street analysts have given Harvard Bioscience a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Harvard Bioscience wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Harvard Bioscience's next earnings date?

Harvard Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Harvard Bioscience
.

How were Harvard Bioscience's earnings last quarter?

Harvard Bioscience, Inc. (NASDAQ:HBIO) released its quarterly earnings data on Thursday, November, 5th. The medical instruments supplier reported $0.04 earnings per share for the quarter, meeting the consensus estimate of $0.04. The medical instruments supplier had revenue of $24.04 million for the quarter. Harvard Bioscience had a positive return on equity of 4.29% and a negative net margin of 6.51%.
View Harvard Bioscience's earnings history
.

What price target have analysts set for HBIO?

3 brokerages have issued 12 month target prices for Harvard Bioscience's shares. Their forecasts range from $4.00 to $4.00. On average, they anticipate Harvard Bioscience's stock price to reach $4.00 in the next year. This suggests that the stock has a possible downside of 6.3%.
View analysts' price targets for Harvard Bioscience
or view Wall Street analyst' top-rated stocks.

Who are some of Harvard Bioscience's key competitors?

What other stocks do shareholders of Harvard Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Harvard Bioscience investors own include Bank of Hawaii (BOH), InterDigital (IDCC), STAG Industrial (STAG), NVIDIA (NVDA), LightPath Technologies (LPTH), Micron Technology (MU), Nokia (NOK), Evoke Pharma (EVOK), General Electric (GE) and Gilead Sciences (GILD).

Who are Harvard Bioscience's key executives?

Harvard Bioscience's management team includes the following people:
  • Mr. James W. Green, Pres, CEO & Chairman (Age 63, Pay $594.19k)
  • Mr. Michael A. Rossi, Chief Financial Officer (Age 47, Pay $321.2k)
  • Mr. Kenneth Fletcher Olson, Chief Operating Officer (Age 59)
  • Mr. Jacques Coumans Ph.D., Chief Marketing Officer
  • David Sirois, Director of Corp. Accounting & SEC Reporting

What is Harvard Bioscience's stock symbol?

Harvard Bioscience trades on the NASDAQ under the ticker symbol "HBIO."

Who are Harvard Bioscience's major shareholders?

Harvard Bioscience's stock is owned by many different institutional and retail investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.61%) and Sowell Financial Services LLC (0.02%). Company insiders that own Harvard Bioscience stock include Alan I Edrick, Bertrand Loy, James W Green, Jeffrey Duchemin, Katherine A Eade, Thomas W Loewald and Value Fund Lp Palogic.
View institutional ownership trends for Harvard Bioscience
.

Which major investors are selling Harvard Bioscience stock?

HBIO stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co..
View insider buying and selling activity for Harvard Bioscience
or view top insider-selling stocks.

Which major investors are buying Harvard Bioscience stock?

HBIO stock was acquired by a variety of institutional investors in the last quarter, including Sowell Financial Services LLC. Company insiders that have bought Harvard Bioscience stock in the last two years include Alan I Edrick, Bertrand Loy, James W Green, Katherine A Eade, Thomas W Loewald, and Value Fund Lp Palogic.
View insider buying and selling activity for Harvard Bioscience
or or view top insider-buying stocks.

How do I buy shares of Harvard Bioscience?

Shares of HBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Harvard Bioscience's stock price today?

One share of HBIO stock can currently be purchased for approximately $4.27.

How big of a company is Harvard Bioscience?

Harvard Bioscience has a market capitalization of $166.43 million and generates $116.18 million in revenue each year. The medical instruments supplier earns $-4,690,000.00 in net income (profit) each year or $0.12 on an earnings per share basis. Harvard Bioscience employs 505 workers across the globe.

What is Harvard Bioscience's official website?

The official website for Harvard Bioscience is www.harvardbioscience.com.

How can I contact Harvard Bioscience?

Harvard Bioscience's mailing address is 84 OCTOBER HILL RD, HOLLISTON MA, 01746. The medical instruments supplier can be reached via phone at 508-893-8999 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.